Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lundbeck
Lundbeck
Lundbeck to advance schizophrenia drug solo after taking an ax to early-stage pipeline
Fierce Biotech
Thu, 08/20/15 - 09:14 am
Lundbeck
schizophrenia
Lu AF35700
Troubled Lundbeck targets 1,000 layoffs in HQ, commercial revamp
Fierce Pharma
Wed, 08/19/15 - 09:11 am
Lundbeck
layoffs
reorganization
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
BioPharma Dive
Mon, 07/13/15 - 09:51 am
FDA
Otsuka
Lundbeck
schizophrenia
Rexulta
FDA approves Otsuka and Lundbeck's schizophrenia treatment
Yahoo/Reuters
Fri, 07/10/15 - 10:53 pm
FDA
Otsuka
Lundbeck
schizophrenia
Rexulti
antipsychotics
Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs
Forbes
Thu, 06/18/15 - 11:03 am
clinical depression
Brintellix
Lundbeck
Former Novo exec Schultz will become a CEO after all—just at another pharma
BioPharma Dive
Thu, 05/7/15 - 11:00 am
Novo Nordisk
Pharma CEOs
Lundbeck
Kåre Schultz
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Lundbeck pulls the plug on its fast-tracked stroke drug
Fierce Biotech
Thu, 12/18/14 - 10:25 am
Lundbeck
stroke
desmoteplase
Lundbeck CEO Leaves After Failing to Report Receiving Shares
Bloomberg
Mon, 11/24/14 - 09:43 am
Lundbeck
Pharma CEOs
Ulf Wiinberg
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thu, 10/30/14 - 12:22 pm
M&A
Avanir
Alzheimer's disease
Lundbeck
Eli Lilly
Mallinckrodt
Shire
Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year
Yahoo
Tue, 06/24/14 - 10:26 am
Lundbeck
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside
Seeking Alpha
Thu, 05/29/14 - 09:35 am
Chelsea Therapeutics
Lundbeck
This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes
Motley Fool
Sat, 05/10/14 - 12:45 pm
Chelsea Therapeutics
Corcept Therapeutics
Lundbeck
Theravance
GSK
AstraZeneca
Amgen
Lundbeck to acquire Chelsea Therapeutics for up to $658 mln
Reuters
Thu, 05/8/14 - 08:33 am
Lundbeck
Chelsea Therapeutics
M&A
Lundbeck says to launch new Alzheimer drug in 2017
Reuters
Mon, 12/16/13 - 08:07 am
Lundbeck
Alzheimer's disease
Lu AE58054
Think fast: A new cognition study could add $350M to Lundbeck's Brintellix sales
Fierce Pharma
Thu, 12/12/13 - 11:24 am
Lundbeck
Brintellix
antidepressants
Lundbeck, Otsuka start trials for Alzheimer's drug
Reuters
Thu, 10/10/13 - 08:31 am
Otsuka
Lundbeck
Alzheimer's disease
Lu AE58054
Lundbeck, Takeda Win U.S. Approval for Depression Therapy
Bloomberg
Tue, 10/1/13 - 08:49 am
Lundbeck
Takeda
FDA
Brintellix
major depressive disorder
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Europe
drug approvals
Kadcyla
Roche
Bayer
Xofigo
Abilify Maintena
Otsuka
Lundbeck
Memantine Accord
Accord Healthcare
Levodopa Carbidopa Entacapone Sandoz
Orion
Vitekta
Gilead
Janssen-Cilag
Invokana
Novo Nordisk
NovoEight
AstraZeneca
Fluenz Tetra
GSK
Relvar Ellipta
Lidocaine/Prilocaine Plethora
Plethora Solutions
Lundbeck, Otsuka get positive opinion for schizophrenia drug
Reuters
Fri, 09/20/13 - 09:42 am
Otsuka
Lundbeck
Europe
schizophrenia
Abilify Maintena
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »